Growth deficiency in a mouse model of Kabuki syndrome 2 bears mechanistic similarities to Kabuki syndrome 1

Christine W. Gao,WanYing. Lin,Ryan C. Riddle,Sheetal. Chopra,Jiyoung. Kim,Leandros. Boukas,Kasper D. Hansen,Hans T. Björnsson,Jill A. Fahrner
DOI: https://doi.org/10.1371/journal.pgen.1011310
IF: 4.5
2024-06-11
PLoS Genetics
Abstract:Growth deficiency is a characteristic feature of both Kabuki syndrome 1 (KS1) and Kabuki syndrome 2 (KS2), Mendelian disorders of the epigenetic machinery with similar phenotypes but distinct genetic etiologies. We previously described skeletal growth deficiency in a mouse model of KS1 and further established that a Kmt2d -/- chondrocyte model of KS1 exhibits precocious differentiation. Here we characterized growth deficiency in a mouse model of KS2, Kdm6a tm1d/+ . We show that Kdm6a tm1d/+ mice have decreased femur and tibia length compared to controls and exhibit abnormalities in cortical and trabecular bone structure. Kdm6a tm1d/+ growth plates are also shorter, due to decreases in hypertrophic chondrocyte size and hypertrophic zone height. Given these disturbances in the growth plate, we generated Kdm6a -/- chondrogenic cell lines. Similar to our prior in vitro model of KS1, we found that Kdm6a -/- cells undergo premature, enhanced differentiation towards chondrocytes compared to Kdm6a +/+ controls. RNA-seq showed that Kdm6a -/- cells have a distinct transcriptomic profile that indicates dysregulation of cartilage development. Finally, we performed RNA-seq simultaneously on Kmt2d -/- , Kdm6a -/- , and control lines at Days 7 and 14 of differentiation. This revealed surprising resemblance in gene expression between Kmt2d -/- and Kdm6a -/- at both time points and indicates that the similarity in phenotype between KS1 and KS2 also exists at the transcriptional level. Mendelian disorders of the epigenetic machinery (MDEMs) are an individually rare but collectively common group of disorders that disrupt neurodevelopment and growth. We have focused on abnormal skeletal growth. MDEMs are caused by disruption of genes encoding components of the epigenetic machinery, which ultimately lead to broadly altered cellular gene expression patterns. These disorders can therefore inform our understanding of epigenomic and transcriptomic mechanisms underlying normal and aberrant skeletal growth. We previously elucidated novel mechanisms contributing to overgrowth in Weaver syndrome and to growth deficiency in Kabuki syndrome 1. Here, we elucidate the skeletal growth deficiency phenotype in a mouse model of Kabuki syndrome 2, which resembles some aspects in Kabuki syndrome 1 mice and the human disease. We observe shortened bones with altered structure, involving reduced growth plate height and chondrocyte cell size in our mice. Moreover, we establish precocious differentiation of chondrocytes as a cellular mechanism and observe a disproportionate upregulation of chondrogenic genes. Remarkably, gene expression changes in Kabuki syndrome 2 chondrocytes substantially overlap with Kabuki syndrome 1. This suggests shared disease mechanisms between the disorders at the level of gene expression, which may facilitate targeting both disorders with a single therapy in the future.
genetics & heredity
What problem does this paper attempt to address?